Valsartan, an angiotensin II receptor blocker drug, delayed disease progression and improved cardiac structure and function in patients with early-stage hypertrophic cardiomyopathy, according to ...

Amsterdam, NL, February, 26. 2015 - The muscular dystrophies are known to target various muscle groups differentially. In addition to making limb muscles weak, muscular dystrophy (MD) can also lead to ...

The next time you train, remember: You’re not just building endurance. You’re upgrading your heart's software. You're ...

Researchers have developed a scalable bioreactor-based system to produce cardiac organoids that successfully integrated into ...